Preparing biologics for commercialization: Understanding Strategies to Reduce Risk and Optimize Outcomes in Drug Development


Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product. Different players step in during each point, so keeping a program with many moving parts on track requires planning and time-tested execution approaches. An integrated Contract Development and Manufacturing Organization (CDMO) with the ability to carry out the late-stage development can ease the pain at each point.